Clinical Trial Information Request for Protocol 2025P001003 Title Invest-HD: A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of Votoplam in participants with Huntington’s Disease PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone